News & Insights

Tarsus Pharmaceuticals announces its definitive agreement to acquire Alkeus Pharmaceuticals, a privately held retinal disease-focused biotechnology company developing gildeuretinol (ALK-001), an investigational once-daily oral therapy for Stargardt disease.

Gunderson Dettmer represented Stainless in its acquisition by Anthropic. Stainless is a New York-based startup that automates the creation and maintenance of software development kits (SDKs), the libraries developers use to interact with APIs.